| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
0.25 |
0.5 |
0.06 － 2 |
Minocycline (Minocycline hydrochloride, Minocin)  |
476 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
0.25 |
0.5 |
? － ? |
Quinupristin/Dalfopristin (Synercid) |
39 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
0.25 |
0.5 |
? － ? |
Tigecycline (GAR-936, Tigacyl) |
39 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
>0.25 |
>16 |
≤0.12 － >16 |
Clindamycin (Cleocin) |
18 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
0.5 |
1 |
0.12 － 2 |
Tigecycline (GAR-936, Tigacyl) |
476 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
1 |
1 |
0.5 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
265 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
1 |
1 |
? － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
39 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
>1 |
>4 |
≤0.5 － >4 |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
265 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
>1 |
>4 |
? － ? |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
39 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
1 |
8 |
0.12 － 32 |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
476 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
2 |
2 |
1 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
265 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
>2 |
>2 |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
39 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
2 |
2 |
? － ? |
Vancomycin (Vancocyn, Lyphocin) |
126 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
2 |
2 |
? － ? |
Vancomycin (Vancocyn, Lyphocin) |
39 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
>2 |
>8 |
≤2 － >8 |
Gentamicin (Gentamycin, Garamycin) |
265 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
2 |
64 |
0.25 － >128 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
476 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
>4 |
>8 |
? － ? |
Tetracycline (Sumycin, Achromycin V, Steclin) |
39 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
>8 |
>8 |
0.12 － >8 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
265 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
>8 |
>8 |
? － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
39 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
>16 |
>32 |
? － ? |
Imipenem |
126 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
>32 |
>32 |
? － ? |
Cefepime (Maxipime) |
126 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
>32 |
>32 |
? － ? |
Ceftriaxone (Rocephin) |
126 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
>256 |
>256 |
? － ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
126 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
>256 |
>256 |
? － ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
126 |
| Staphylococci (coagulase-negative + oxacillin-resistant) |
- |
4 |
>16 － ? |
Chloramphenicol (Chloromycetin) |
39 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.023 |
0.047 |
? － ? |
Imipenem |
126 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.06 |
0.12 |
? － ? |
Clindamycin (Cleocin) |
39 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.12 |
0.25 |
≤0.06 － >8 |
Clindamycin (Cleocin) |
412 |